𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Stiff person syndrome: Advances in pathogenesis and therapeutic interventions

✍ Scribed by Marinos C. Dalakas

Book ID
107558995
Publisher
Springer
Year
2009
Tongue
English
Weight
287 KB
Volume
11
Category
Article
ISSN
1092-8480

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A therapeutic trial of milacemide in myo
A therapeutic trial of milacemide in myoclonus and the stiff-person syndrome
✍ P. Brown; P. D. Thompson; J. C. Rothwell; B. L. Day; Prof. C. D. Marsden πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 269 KB πŸ‘ 1 views

We investigated the therapeutic effects of milacemide in seven patients with myoclonus and three patients with the stiff-person syndrome in an open-label trial. Milacemide was initiated at 800 mg/day and was gradually increased to a maximum dosage of 2,400 mg/day. No significant improvement occurred

Quality of life in stiff person syndrome
Quality of life in stiff person syndrome
✍ Willibald Gerschlager; Anette Schrag; Peter Brown πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 75 KB

## Abstract Stiff person syndrome (SPS) is a rare, chronic disorder characterized by painful spasm and stiffness. We investigated the quality of life (QoL) in SPS patients, and identified factors associated with impairment in patients' QoL. Twenty‐four SPS patients (10 men, 14 women; mean age Β± S.D

PET evidence of central GABAergic change
PET evidence of central GABAergic changes in stiff-person syndrome
✍ Daniela Perani; Valentina Garibotto; Andrea Panzacchi; Rosa Maria Moresco; Paola πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 80 KB

## Abstract We measured expression of central nervous system GABA‐A receptors with ^11^C‐flumazenil (^11^C‐FMZ) and PET in two subjects with stiff person syndrome (SPS). We found reduced ^11^C‐FMZ binding potential (BP) in motor‐premotor cortex, and increased ^11^C‐FMZ BP in the cerebellar nuclei.